FASEB SRC on Liver Biology: Fundamental Mechanisms and Translational Applications
FASEB SRC on Liver Biology: Fundamental Mechanisms and Translational Applications
批准号:
9121124
负责人:
Robert F. Schwabe
金额:
$3.0万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-05-01 至 2017-04-30
关键词:
AmericanAreaAwardBasic ScienceBiologyClinicalClinical TreatmentCollaborationsDiseaseDoctor of PhilosophyEducationEnsureEnvironmentFatty LiverFloridaFosteringFunctional disorderGene ExpressionGoalsHealthHepaticHepatobiliaryHepatologyInflammationInternationalLinkLiverLiver FibrosisLiver RegenerationLiver Stem CellLiver diseasesMalignant neoplasm of liverMedicineMetabolismMinorityOrganogenesisPatient CarePostdoctoral FellowRegenerative MedicineRegulationResearchResearch PersonnelScienceSocietiesStagingStressTranslational ResearchTranslationsUnderrepresented MinorityWomanabstractingcareerinnovationliver injuryliver metabolismmedical specialtiesmeetingsminority investigatorminority scientistnovelposterspreferenceprogramspublic health relevancesymposiumtumor metabolism
中文摘要
英文摘要
DESCRIPTION (provided by applicant):
The current application seeks partial support for the Federation of American Societies for Experimental Biology (FASEB) Science Research Conference on "Liver Biology: Fundamental Mechanisms and Translational Applications". For the past 20 years, this meeting has been held biennially and is now recognized as the world's premier conference covering all aspects of basic science research involving the liver. The conference will be held from June 26-July 1, 2016, in West Palm Beach, Florida. The main goals of the conference are to i) integrate the research advances offered by disparate areas of liver biology in order to foster new collaborative projects on both national and international scale, ii) encourage junior and early stage investigators, women and minority scientists to pursue liver research to ensure that the study of hepatic disease and biology remains vigorous and iii) accelerate translation of fundamental advances in liver biology into novel clinical treatments through the interactions of basic and clinical researchers. These goals will be achieved through specific programmatic strategies. The program is divided into nine major sessions and includes presentations from forty-five invited speakers. In addition, these sessions will accommodate multiple short 'late-breaking' talks that will be chosen to represent the most significant and timely research advances in liver research. Preference will be given to junior, minority and women investigators. The program also provides poster and "meet-the-expert" sessions for one-on- one dialogue and several additional opportunities for informal, yet intimate scientific exchange among speakers and attendees throughout the stay. While the conference will keep the tradition of covering a wide range of basic science and translational topics - including liver organogenesis, regulation of hepatobiliary
gene expression in health and disease, liver regeneration, liver injury and fibrosis, liver stem cells and regenerative medicine - there will be particular focus on hepatic metabolisms and fatty liver as well as liver cancer due to their growing relevance. For all topics, emphasis is given to translational application of recent and current discoveries. In summary, the program integrates the most relevant and timely topics in basic and applied aspects of liver health and disease to promote scientific exchange, dissemination, education and collaboration and translation to patient care.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Columbia University Digestive and Liver Disease Research Center
-
批准号:10612948
-
项目类别:
-
资助金额:$121.89万
-
财政年份:2022
-
负责人:Robert F. Schwabe
-
依托单位:
The Columbia University Digestive and Liver Disease Research Center
-
批准号:10443133
-
项目类别:
-
资助金额:$122.99万
-
财政年份:2022
-
负责人:Robert F. Schwabe
-
依托单位:
The Administrative Core
-
批准号:10443134
-
项目类别:
-
资助金额:$24.56万
-
财政年份:2022
-
负责人:Robert F. Schwabe
-
依托单位:
The Administrative Core
-
批准号:10612949
-
项目类别:
-
资助金额:$24.62万
-
财政年份:2022
-
负责人:Robert F. Schwabe
-
依托单位:
Tumor-promoting and tumor-suppressive roles of Hepatic Stellate Cell Subpopulations in NASH-HCC
-
批准号:10278434
-
项目类别:
-
资助金额:$53.5万
-
财政年份:2021
-
负责人:Robert F. Schwabe
-
依托单位:
Protective and fibrosis-independent functions of hepatic stellate cells
-
批准号:10597076
-
项目类别:
-
资助金额:$51.8万
-
财政年份:2021
-
负责人:Robert F. Schwabe
-
依托单位:
Protective and fibrosis-independent functions of hepatic stellate cells
-
批准号:10378664
-
项目类别:
-
资助金额:$53.22万
-
财政年份:2021
-
负责人:Robert F. Schwabe
-
依托单位:
Tumor-promoting and tumor-suppressive roles of Hepatic Stellate Cell Subpopulations in NASH-HCC
-
批准号:10454375
-
项目类别:
-
资助金额:$51.51万
-
财政年份:2021
-
负责人:Robert F. Schwabe
-
依托单位:
Tumor-promoting and tumor-suppressive roles of Hepatic Stellate Cell Subpopulations in NASH-HCC
-
批准号:10654714
-
项目类别:
-
资助金额:$50.19万
-
财政年份:2021
-
负责人:Robert F. Schwabe
-
依托单位:
DAMPs and Their Receptors Link Hepatocyte Death to HSC Activation and Liver Fibrosis
-
批准号:10224799
-
项目类别:
-
资助金额:$52.0万
-
财政年份:2019
-
负责人:Robert F. Schwabe
-
依托单位:
DAMPs and Their Receptors Link Hepatocyte Death to HSC Activation and Liver Fibrosis
-
批准号:9917105
-
项目类别:
-
资助金额:$52.0万
-
财政年份:2019
-
负责人:Robert F. Schwabe
-
依托单位:
DAMPs and Their Receptors Link Hepatocyte Death to HSC Activation and Liver Fibrosis
-
批准号:10453767
-
项目类别:
-
资助金额:$52.0万
-
财政年份:2019
-
负责人:Robert F. Schwabe
-
依托单位:
DAMPs and Their Receptors Link Hepatocyte Death to HSC Activation and Liver Fibrosis
-
批准号:10021026
-
项目类别:
-
资助金额:$52.0万
-
财政年份:2019
-
负责人:Robert F. Schwabe
-
依托单位:
TAZ and YAP in Non-Alcoholic Steatohepatitis and its Complications
-
批准号:9473156
-
项目类别:
-
资助金额:$66.41万
-
财政年份:2018
-
负责人:Robert F. Schwabe
-
依托单位:
HMGB1 as Link Between Hepatocellular Injury and HCC
-
批准号:9258403
-
项目类别:
-
资助金额:$44.38万
-
财政年份:2016
-
负责人:Robert F. Schwabe
-
依托单位:
HMGB1 as Link Between Hepatocellular Injury and HCC
-
批准号:9888333
-
项目类别:
-
资助金额:$44.38万
-
财政年份:2016
-
负责人:Robert F. Schwabe
-
依托单位:
Hepatic Stellate Cells and Liver Cancer
-
批准号:8801797
-
项目类别:
-
资助金额:$37.02万
-
财政年份:2015
-
负责人:Robert F. Schwabe
-
依托单位:
Hepatic Stellate Cells and Liver Cancer
-
批准号:9003035
-
项目类别:
-
资助金额:$35.83万
-
财政年份:2015
-
负责人:Robert F. Schwabe
-
依托单位:
Promotion of Hepatocellular Carcinoma by Myofibroblasts
-
批准号:8256908
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2011
-
负责人:Robert F. Schwabe
-
依托单位:
Promotion of Hepatocellular Carcinoma by Myofibroblasts
-
批准号:8555377
-
项目类别:
-
资助金额:$18.03万
-
财政年份:2011
-
负责人:Robert F. Schwabe
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: